Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 FacebookTwitterPinterestEmail previous post Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements Related Posts ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 May 20, 2025 Reserve and Resource Update May 20, 2025 US$200 Silver? 3 Experts Talk Price, Supply and Demand May 20, 2025 High-grade results incl 16m @ 8g/t Au in Menzies drilling May 20, 2025 Apollo Silver’s Vision: From Founding to Future in Precious Metals... May 20, 2025 Silver Crown Royalties Announces Non-Brokered Private Placement May 20, 2025
